Ratings Capita plc OTC Markets

Equities

CTAGY

US13970R1095

Market Closed - OTC Markets Other stock markets 07:00:02 11/03/2024 pm IST			5-day change	1st Jan Change
0.73 ^USD	-23.96%		-.--%	-23.96%

07/05	AstraZeneca target raised; Antofagasta lowered	AN
02/05	Capita CFO to Retire in August; Successor Named	MT

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 3.59 and 3.6 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The stock, which is currently worth 2024 to 0.3 times its sales, is clearly overvalued in comparison with peers.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
Over the past four months, analysts' average price target has been revised downwards significantly.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Business Support Services

	1st Jan change	Capi.	ESG Refinitiv
CAPITA PLC	-23.96%	299M	-
CINTAS CORPORATION	+14.89%	69.78B	B+
JACOBS SOLUTIONS INC.	+6.09%	17.26B	B+
RB GLOBAL, INC.	+13.68%	14.01B	B-
BUREAU VERITAS SA	+21.56%	13.52B	A-
INTERTEK GROUP PLC	+15.50%	9.99B	B-
TELEPERFORMANCE SE	-17.00%	6.96B	C
GENPACT LIMITED	-0.69%	6.13B	A-
MAXIMUS, INC.	+3.77%	5.25B	B-
EXLSERVICE HOLDINGS, INC.	-0.84%	4.92B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes